Stock Track | Nuvation Bio Plummets 25.26% Intraday on Earnings Miss and Analyst Downgrade

Stock Track03-03 22:44

Nuvation Bio Inc. (NUVB) shares plummeted 25.26% during intraday trading on Tuesday, marking a significant decline for the biotechnology stock.

The sharp drop follows the company's recent fourth-quarter earnings report, which revealed a loss of $0.11 per share. This result missed the analyst consensus estimate of a $0.09 loss by 22.22%, disappointing investors despite the company's quarterly sales surpassing expectations.

Adding to the negative sentiment, UBS adjusted its price target on Nuvation Bio downward to $7 from $10 while maintaining a Neutral rating. The combination of an earnings miss and a reduced price target from a major analyst firm contributed to the severe sell-off in the stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180923020?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-03 22:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180923020","market":"nz","top_or_hot":-1,"title":"Stock Track | Nuvation Bio Plummets 25.26% Intraday on Earnings Miss and Analyst Downgrade","media":"Stock Track","content":"<p>Nuvation Bio Inc. (NUVB) shares plummeted 25.26% during intraday trading on Tuesday, marking a significant decline for the biotechnology stock.</p><p>The sharp drop follows the company's recent fourth-quarter earnings report, which revealed a loss of $0.11 per share. This result missed the analyst consensus estimate of a $0.09 loss by 22.22%, disappointing investors despite the company's quarterly sales surpassing expectations.</p><p>Adding to the negative sentiment, UBS adjusted its price target on Nuvation Bio downward to $7 from $10 while maintaining a Neutral rating. The combination of an earnings miss and a reduced price target from a major analyst firm contributed to the severe sell-off in the stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Nuvation Bio Plummets 25.26% Intraday on Earnings Miss and Analyst Downgrade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Nuvation Bio Plummets 25.26% Intraday on Earnings Miss and Analyst Downgrade\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-03 22:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nuvation Bio Inc. (NUVB) shares plummeted 25.26% during intraday trading on Tuesday, marking a significant decline for the biotechnology stock.</p><p>The sharp drop follows the company's recent fourth-quarter earnings report, which revealed a loss of $0.11 per share. This result missed the analyst consensus estimate of a $0.09 loss by 22.22%, disappointing investors despite the company's quarterly sales surpassing expectations.</p><p>Adding to the negative sentiment, UBS adjusted its price target on Nuvation Bio downward to $7 from $10 while maintaining a Neutral rating. The combination of an earnings miss and a reduced price target from a major analyst firm contributed to the severe sell-off in the stock.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NUVB","symbol_name":"Nuvation Bio, Inc.","start_time":0,"source_url":"","article_id":"1180923020","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180923020","pubTimestamp":1772549076,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Nuvation Bio Inc. (NUVB) shares plummeted 25.26% during intraday trading on Tuesday, marking a significant decline for the biotechnology stock.The sharp drop follows the company's recent...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NUVB":"Nuvation Bio, Inc."},"translate_title":"个股追踪|Nuvation Bio盘中暴跌25.26%因盈利未达预期及分析师下调评级","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NUVB":1},"content_text":"Nuvation Bio Inc. (NUVB) shares plummeted 25.26% during intraday trading on Tuesday, marking a significant decline for the biotechnology stock.The sharp drop follows the company's recent fourth-quarter earnings report, which revealed a loss of $0.11 per share. This result missed the analyst consensus estimate of a $0.09 loss by 22.22%, disappointing investors despite the company's quarterly sales surpassing expectations.Adding to the negative sentiment, UBS adjusted its price target on Nuvation Bio downward to $7 from $10 while maintaining a Neutral rating. The combination of an earnings miss and a reduced price target from a major analyst firm contributed to the severe sell-off in the stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180923020","isCrawlerRequest":true}